Activity of the Cancer Metabolism Inhibitor MPC-9528 in Xenograft Models: Comparison of Different Dosing Schedules.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.10529
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2011
Authors
Publisher
American Society of Clinical Oncology (ASCO)